OCT 18, 2018 6:37 AM PDT

Potential Drug Target for Tactile Allodynia

WRITTEN BY: Nouran Amin

According to research published in the journal Science Translational Medicine in collaboration with a study led by the National Institutes of Health, a new protein found in neuronal cells was identified by researchers at Scripps Research to be implicated in tactile allodynia; a painful sensation caused by light touch and often associated with neuropathy.

Watch Video Below To Learn More about Tactile Allodynia:

The protein identified is PIEZO2 which was originally discovered in the laboratory of Professor Ardem Patapoutian, who worked significantly on the role of allodynia in mice. These studies also confirmed that PIEZO2 was responsible for allodynia in humans. “These two studies provide validation that targeting PIEZO2 could be beneficial in the clinic,” explains Prof. Patapoutian.

During the studies, researchers had used various induction methods for allodynia including the utilization of a neuronal sensitive chemical molecule, capsacin, which is found in a chili pepper, and known to cause inflammation. “We hope that these results will help researchers develop better treatments for managing this common form of pain,” said study author Alexander T. Chesler, PhD, who is also a Stadtman Investigator at the NIH’s National Center for Complementary and Integrative Health (NCCIH).

Image via Drug Target Review

Furthermore, first author of the study—Dr. Swetha Murthy had examined the research to focus on mice who had gentle reactions to touch after exposure to capsaicin. Findings concluded that non-genetically altered normal mice had experienced allodynia. However, the mice that were altered, or had the PIEZO2 gene “knocked out”, did not experience allodynia by not reacting to the capsaicin exposure. Additionally, the findings were also exhibited in human patients who had mutations in their PIEZO2 gene expression. “It was very gratifying to see this in both studies,” says Dr. Murthy. “It usually takes years to confirm if results observed in mice hold true in humans, so I think it was mutually exciting for both groups.”

The researchers are looking forward to examine exactly how inflammation is implicated with normal touch signals and to determine a cause. They also wish to identify potential molecules that can act as PIEZO2 blockers that may one day relieve patients from neuropathic pain.

Source: Science Transitional Method, Drug Target Review

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
MAY 07, 2020
Cancer
MAY 07, 2020
Yet Another Cancer Linked Tyrosine Kinase
In a cell, there are tens of thousands of individual components. Each component has a specific activity or role that the ...
MAY 08, 2020
Drug Discovery & Development
MAY 08, 2020
Cholesterol Drugs May Boost Healthy Gut Bacteria in Obese People
While statins have long been known for their efficacy in treating high cholesterol, until recently, there was no evidenc ...
MAY 12, 2020
Drug Discovery & Development
MAY 12, 2020
Does Herbal Drink from Madagascar Cure COVID-19?
Andry Rajoelina, the president of Madagascar, an island off the coast of Southern Africa, has made claims that his count ...
MAY 18, 2020
Cancer
MAY 18, 2020
How do Ohnologs affect Cancer?
Genetics can be complicated to say the least. Sometimes it can be as simple as a single mutation in one gene that causes ...
JUN 09, 2020
Drug Discovery & Development
JUN 09, 2020
Psychedelic DMT Improves Wellbeing in 89% of People
DMT is a powerful psychedelic drug known to produce visions involving 'other beings' like elves, aliens, and dei ...
JUN 18, 2020
Drug Discovery & Development
JUN 18, 2020
FDA Cancels Emergency Approval for Hydroxychloroquine
The US Food and Drug Administration (FDA) has decided to cancel emergency use authorization for Hydroxychloroquine and C ...
Loading Comments...